Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Trial Registrations Must Have “Useful Information,” Journal Editors Say

This article was originally published in The Pink Sheet Daily

Executive Summary

International Committee of Medical Journal Editors says some manufacturers are using a “meaningless phrase” in place of a drug’s name for trial registries. Editors adopt WHO minimal registration data set of 20 items; registrations with missing fields or fields with “uninformative terminology” will be considered “inadequate.”
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS062258

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel